NCT07592611
Deep Brain Stimulation for Treatment-Resistant Schizophrenia
StatusNot Yet Recruiting
PhaseNot applicable
SponsorJohns Hopkins University
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Start date pushed from Nov 1, 2026 to Jan 1, 2027
- Notable Start date pushed from Oct 1, 2026 to Nov 1, 2026
- Eligibility criteria expanded, about 21 words
- Secondary endpoints: details revised at 2 of 2 entries
- Notable Start date: Sep 1, 2026 to Oct 1, 2026v4
- Notable Start date: Aug 1, 2026 to Sep 1, 2026v3
- Notable Start date: Jun 1, 2026 to Aug 1, 2026v2
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Change from baseline in the Brief Psychiatric Rating Scale
Timeframe: 1 year after neurostimulator implantation
Change from baseline in the Scales for the Assessment of Negative Symptoms (SANS)
Timeframe: 1 year after neurostimulator implantation
Incidence of adverse device effects (ADEs).
Timeframe: 1 year after neurostimulator implantation
Secondary (2)
Change from baseline in the Young Mania scale (YMS)
Change from baseline in the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) cognitive test battery.
Arms and interventions
Deep Brain Stimulation ImplantExperimental
Unblinded treatment arm, deep brain stimulation of the substantia nigra pars reticulata for treatment resistant schizophrenia.
Devices: Medtronic Percept with SensSight Deep Brain Stimulation System
Sites
1 site in 1 country
- The Johns Hopkins HospitalBaltimore, Maryland, United States